ACON | Aclarion, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	4.65 - 5.39
52 Week Range	3.86 - 408.70
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	213,009
Average Volume	399,732
Shares Outstanding	1,015,885
Market Cap	5,191,172
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2022-04-22

Valuation
Profitability
Growth
Health
P/E Ratio	-0.01
Forward P/E Ratio	N/A
EPS	-804.49
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	ACON

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

ACON's peers: OPRX, SY, EUDA, FOXO, AUGX, ETAO, AKLI, HCTI, MGRX, HSTM, NRC, FORA, ACONW, WGS, BFRG

*Chart delayed

Analyzing fundamentals for ACON we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see ACON Fundamentals page.

Watching at ACON technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ACON Technicals page.